https://www.selleckchem.com/products/acy-775.html
All rights reserved.Cutaneous T-cell lymphoma (CTCL) is a chronic condition with low malignancy. International treatment guidelines for CTCL are widely followed in Europe and the USA. Combination therapy with therapeutic agents for CTCL and phototherapy is effective on the basis of European data. The efficacy and safety of combination therapy for Japanese CTCL patients are not established. We investigated the efficacy and safety of combination therapy with photchemo)therapy and bexarotene in Japanese CTCL patients. Twenty-five patient
Aimer
Commentaire
Partagez
